Vertex Pharmaceuticals (VRTX34.SA) Q2 2017 Earnings

27AprConfirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
0.5
0.77
1.04
1.3

Details

Expected EPS
1.0497135000000002
Actual EPS
1.3041895
Surprise EPS
0.25
Surprise Percent
+24.24%

Description

Vertex Pharmaceuticals (VRTX34.SA) has reported earnings of 1.3041895 per share for Q2 2017.

0 Comments

Share your thoughts